Arnaud Roth

Prognostic Role of <i>KRAS</i> and <i>BRAF</i> in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Arnaud Roth, Sabine Tejpar, Mauro Delorenzi et al. · Journal of Clinical Oncology · 2009 · 1.1K citations · Full text

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Eric Van Cutsem, Roberto Labianca, G. Bodoky et al. · Journal of Clinical Oncology · 2009 · 466 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +13

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Daniel Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch et al. · Journal of Clinical Oncology · 2003 · 440 citations

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

Eva Budínská, Vlad Popovici, Sabine Tejpar et al. · The Journal of Pathology · 2013 · 411 citations · Full text

Engineering, Genetics, Pathology +18

EURECCA colorectal: Multidisciplinary management: European consensus conference colon &amp; rectum

Cornelis J.�H. van de Velde, Petra G. Boelens, Josep M. Borràs et al. · European Journal of Cancer · 2013 · 399 citations

Surgical Oncology, Multidisciplinary Management, Colorectal Surgery +7